Connor, Clark & Lunn Investment Management (CC&L)
QTTB icon

Connor, Clark & Lunn Investment Management (CC&L)’s Q32 Bio QTTB Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-645
Closed -$13.6K – 1591
2023
Q3 		$13.6K Sell
645
-4,500
-87% -$91.7K ﹤0.01% 1331
2023
Q2 		$82K Sell
5,145
-4,420
-46% -$79.3K ﹤0.01% 1253
2023
Q1 		$177K Sell
9,565
-1,378
-13% -$34.3K ﹤0.01% 1112
2022
Q4 		$248K Sell
10,943
-1,990
-15% -$52.8K ﹤0.01% 1009
2022
Q3 		$375K Buy
12,933
+311
+2% +$12.7K ﹤0.01% 875
2022
Q2 		$448K Buy
12,622
+1,738
+16% +$59.3K ﹤0.01% 807
2022
Q1 		$596K Sell
10,884
-425
-4% -$26.4K ﹤0.01% 755
2021
Q4 		$741K Buy
11,309
+5,093
+82% +$494K ﹤0.01% 724
2021
Q3 		$880K Buy
6,216
+1,572
+34% +$200K ﹤0.01% 669
2021
Q2 		$608K Buy
+4,644
New +$580K ﹤0.01% 754

Other funds holding QTTB

Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GKFF
George Kaiser Family Foundation Tulsa, Oklahoma $883M AUM 21.04% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s QTTB Position: Q4 2023 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of Q32 Bio (QTTB) in Q4 2023, closing a stake of 645 shares — an estimated $13.6K sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in QTTB in Q2 2021 and held it in 10 quarters. The position peaked at $880K in Q3 2021. 57 funds tracked by Wall St. Rank hold QTTB as of Q4 2023.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining Q32 Bio position as of Q4 2023 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 645 Q32 Bio shares in Q4 2023, an estimated $13.6K.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Q32 Bio in Q2 2021 and held it in 10 quarters.
  • Connor, Clark & Lunn Investment Management (CC&L)'s Q32 Bio position peaked at $880K in Q3 2021.
  • 57 funds tracked by Wall St. Rank held Q32 Bio as of Q4 2023.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q4 2023, filed 9 Feb 2024.